| abstract |
The present invention provides novel protein variants that exhibit a reduced immunogenic response compared to the parent protein. Furthermore, the present invention provides a DNA molecule that encodes the novel variant, a host cell that contains the DNA that encodes the novel variant, and a method for reducing the allergenicity of a protein. Furthermore, the present invention provides various compositions containing these proteins that are less immunogenic than wild-type proteins. |